Multiple cell types and extracellular signaling pathways

The term Multiple cell types and extracellular signaling pathways refers to a broad biological framework rather than a single, discrete therapeutic target. It encompasses the complex interactions between diverse cell populations—such as immune cells, fibroblasts, and endothelial cells—and the myriad of signaling molecules like cytokines, hormones, and growth factors that facilitate intercellular communication (Nature Reviews Drug Discovery, 2017). In the context of pharmacology and drug discovery, a target must be a specific molecular entity, such as a receptor, enzyme, or ion channel, whose activity can be modulated by a ligand to achieve a therapeutic outcome (IUPHAR/BPS Guide to Pharmacology). Because this entry describes a systemic environment or a collection of pathways rather than a specific protein or gene product, it is considered an incorrect or overly broad designation for a drug target. Effective therapeutic intervention requires identifying specific nodes within these pathways, such as Janus kinases or G protein-coupled receptors, to ensure efficacy and minimize non-specific toxicity.

Other names

Cell-cell communication networksIntercellular signaling systemsExtracellular signaling milieu

Not applicable as this is a broad biological category rather than a specific molecular target.